Sodium oligomannate to prevent cognitive decline after ischemic stroke
Official title: Efficacy and Safety of Sodium Oligomannate in the Prevention of Post-stroke Cognitive Impairment in Patients With Ischemic Stroke:a Randomized, Double-blind, Exploratory Controlled Study
Run by Nanfang Hospital, Southern Medical University · NCT05545605 · Data updated 2026-11-12
This will test whether taking sodium oligomannate can prevent cognitive problems in adults who recently had an ischemic stroke.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 116 (estimated) |
| Sponsor | Nanfang Hospital, Southern Medical University Academic / other |
| Locations | 2 sites (Guangzhou, Baiyun and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | June 13, 2025 |
| Trial ID | NCT05545605 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with a first ischemic stroke within 7 days of onset, conscious and able to complete cognitive testing (NIHSS ≤15), with baseline cognitive screening below the study cutoff (MoCA corrected <22), and who can attend follow-up visits at the study site.
✕Probably not a fit
People with severe neurologic deficits, pre-existing neurodegenerative disease or other major brain disorders, inability to cooperate with testing, onset beyond 7 days, or who live too far to attend the scheduled in-person visits are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind, placebo-controlled, single-center study that enrolled 116 adults with a first ischemic stroke to compare sodium oligomannate versus placebo over a 6-month period. Participants were randomized 1:1 and received study medication or matching placebo, with safety checks at 4, 12, and 24 weeks and efficacy assessments at 12 and 24 weeks. Eligible patients were enrolled within 7 days of stroke onset, were able to cooperate with cognitive testing, and had MoCA scores below the study cutoff after education correction. The trial focuses on preventing post-stroke cognitive impairment by targeting gut microbiota-related mechanisms suggested in prior Alzheimer’s research.
Why it matters
Potential benefit: If successful, the treatment could lower the risk of post-stroke cognitive impairment and help preserve daily functioning after ischemic stroke.
How similar studies have gone: Sodium oligomannate has shown cognitive benefits in mild-to-moderate Alzheimer's disease, but its use specifically to prevent post-stroke cognitive impairment is largely untested and requires larger trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1.The first occurrence of ischemic stroke, which met the diagnostic criteria of the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018, was confirmed by CT or MR; 2. The onset of illness was less than 7 days after admission, aged 18-80 years; 3. Clear consciousness, able to cooperate with cognitive and other tests, NIHSS score ≤15; 4. Before onset, the patient's cognitive level was normal, daily life and social activities were normal; 5. Stay in the current place of residence for more than 3 years; 6. With cognitive assessment, MoCA \< 22 (years of education \< 12, +1) after correction, and signed the informed consent. Exclusion Criteria: * 1.Unable to cooperate with neuropsychological examination due to various reasons (such as consciousness disorders, vision disorders, hearing disorders, etc.); 2. Combined with other diseases (such as intracranial mass, demyelinating disease, intracranial infection, neurodegenerative disease, epilepsy, severe heart, liver, kidney, blood system or other system diseases, etc.); 3. Used antibiotics 3 months before onset; 4. A history of alcohol abuse, drug use, or serious mental illness (including major depression (HAMD \> 10)) before onset of illness, 5. No stool was collected within 7 days of onset.
Where it's running
-
Nanfang Hospital, Southern Medical University
Guangzhou, Baiyun, China Recruiting -
Nanfang Hospital,Southern Medical University
Guangzhou, Guangdong, China Not yet recruiting
Study contacts
- Study coordinator: Jia Yin, M.D
- Email: jiajiayin@139.com
- Phone: 13802964883
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Ear-based nerve stimulation to help sleep after a stroke
A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.
-
Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)
This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.
-
Preventing another ischemic stroke with a smart bracelet and app
This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.
-
Photon-counting CT to check intracranial stents
This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.